SUMMARY Glucagon has been shown previously to increase further the enhanced tolerance for hypoxia observed in mice with elevated blood ketones. Glucagon is also known to increase blood glucose and to alter directly the metabolism of some (liver) cells. Both the increase in blood glucose and altered cellular metabolism could contribute to the increase in tolerance for hypoxia observed in mice given glucagon in combination with the ketone, beta-hydroxybutyrate. To evaluate the systemic component of this hypothesis, blood glucose, beta-hydroxybutyrate, and glucagon were elevated alone or simultaneously and hypoxic tolerance of mice was measured. To identify possible cellular effects of glucagon on glucose or ketone metabolism, we measured the incorporation of radiolabled glucose or beta-hydroxybutyrate into CO 2 or total lipid in isolated rat brain slices. Both glucagon and glucose increased hypoxic tolerance of ketotic mice but our data do not support the hypothesis that glucagon's action was only through an elevation of blood glucose. In brain slices glucagon stimulated the incorporation of beta-hydroxybutyrate into CO 2 both in the presence or absence of additional glucose. These results demonstrate that glucagon has a direct effect on brain metabolism which may contribute to the increased tolerance for hypoxia. They, however, do not exclude the possibility that glucagon is working in addition to increase hypoxic survival in ketotic mice by increasing the availability of glucose to the brain.
Stroke Vol 15, No 2, 1984CONTEMPORARY THERAPEUTIC MEASURES for hypoxic-ischemic brain injury involve anticoagulation, antiplatelet agents, volume expansion, hemodilution, induced hypertension, pharmacological vasodilators, barbiturate coma, profound cooling, steroids, diuretics and a variety of other miscellaneous treatments. None of these procedures have met with resounding success. We believe our work on induced ketosis represents a fundamentally different approach to the problem of cerebral protection.Previous studies from our laboratory demonstrated that, when mice were placed in an hypoxic environment, those with elevated blood ketones survived up to five times longer. 1 -2 Furthermore, this enhanced hypoxic tolerance was potentiated by exogenous glucagon (GG). 3 Before such manipulations of blood glucose, ketones or GG can be considered for clinical applicability, some basic understanding of the mechanism by which these procedures increase tolerance for hypoxia would be desirable.In the intact animal GG is known not only to elevate blood glucose but to alter cellular metabolism. 4 For example, it has been reported that acute GG treatment of intact animals alters liver mitochondrial calcium flux and respiration. 3 Furthermore, Suzuki 6 reported that the intravenous injection of GG increases oxygen consumption of subsequently prepared liver slices. In order to discriminate between a direct cellular effect and an indirect systemic effect of GG, Siess and Wieland 7 first isolated hepatocytes and then treated them with GG....